profile picture
Tom Kelleher, Ph.D.
CEO
Xylome Corporation
I'm working on
2 months ago
Commercialization of a bioidentical replacement for RBD palm oil that is made in engineered hyperlipogenic yeast. The product tradename is YOIL®️, a solid fat at room temperature and liquid at body temperature. YOILt meets or exceeds the functionality of refined palm oil,
I'm looking for
3 months ago
Xylome seeks to sell a controlling share of the company to PE or strategic investors, who can help us achieve a the 75% reduction in cost through scale-up, at which point YOIL®️ will be price comparable to the acquisition cost of RBD palm oil, an $8.4B market in NA and the EU.
About
Senior Leadership in Technology Management. Biopharmaceutical and Bioindustrial process development. New facility startups and FDA licensures. Xylome is a technology provider in the synthetic biology space with a focus on sustainable oils made in engineered hyperlipogenic yeast. Our focus areas are a bioidentical replacement for RBD palm oil and a related technology for the use of Patented Large Lipid Body (LLB) Technology for topica drug delivery of hydrophobic active ingredients.
profile picture
Tom Kelleher, Ph.D.
CEO
Xylome Corporation
Work experience
Xylome Corporation
CEO
2014 - Present
Amgen
Global Network Leader for Process Engineering
2003 - 2014
Cubist Pharmaceuticals
Senior Director of Process Development and Manufacturing
1998 - 2003
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Not enough data yet.
Results may appear later and can be imperfect.
Last updated Aug 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.